Ertugliflozin-d9 | MedChemExpress (MCE)
Ertugliflozin-d9 is deuterated labeled Ertugliflozin (HY-15461). Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2[1]. Has the potential for the treatment of type 2 diabetes mellitus[2].
| Trivial name | Ertugliflozin-d9 |
| Catalog Number | HY-15461S1 |
| Alternative Name(s) | PF-04971729-d9 |
| Research Area | Metabolic Disease |
| Purity | ≥98.0% |
| SMILES | ClC1=CC=C([C@]23O[C@@](CO)(CO3)[C@@H](O)[C@H](O)[C@H]2O)C=C1CC4=C([2H])C([2H])=C(OC([2H])([2H])C([2H])([2H])[2H])C([2H])=C4[2H] |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/ertugliflozin-d9.html |